Animal Health Active Pharmaceutical Ingredients Market to Witness CAGR 7.3% Growth in Revenue During the Period 2025

17/mar/2020 09:23:35 persistencemarketresearch Contatta l'autore

Questo comunicato è stato pubblicato più di 30 giorni fa. Le informazioni su questa pagina potrebbero non essere attendibili.

The global animal health active pharmaceutical ingredient (API) market is projected to register an impressive expansion at 7.3% CAGR during the forecast period 2017 to 2025, according to a recent study by Persistence Market Research (PMR). PMR's study estimates the market to increase from revenues worth US $ 5,216.1 Mn in 2017 to reach US $ 9,162.2 Mn by 2025-end.

Limited Insurance or Government Intervention Provides Smooth Flow to the Market Growth in APAC

Asia Pacific (APAC) will continue to be the most lucrative region in the global animal health active pharmaceutical ingredient market, with sales exhibiting the second highest CAGR through 2025. APAC has remained one of the largest API suppliers, at affordable costs. Governments across APAC have been making investments and focusing on local manufacturing facilities of APIs. Favorable policies offered by these governments have been shifting the focus of API manufacturers in moving their production bases to APAC countries, such as India and China. In addition, limited insurance or government intervention provides smooth flow to market growth in these regions.

However, animal health API products manufactured in APAC countries do not meet regulatory standards, and there has been increasing concerns pertaining to the quality of APIs, especially those produced in China and India. Western regulatory bodies are becoming stricter in the inspection of APIs produced in these regions. Manufacturers are further facing challenges in bridging the gap between the cost and quality of APIs. These factors will inhibit growth of the market in APAC.

Get sample Copy of This Rpeort @ https://www.persistencemarketresearch.com/samples/16972

Europe to Remain the Second Largest Market for Animal Health APIs

Europe will remain the second largest market for animal health active pharmaceutical ingredients. Leading healthcare companies are located in the Europe, which in turn has boosted requirement for veterinary APIs in the region. Consumption of veterinary drugs in Europe has surged substantially over the past few years. Spain has been witnessed to be the largest consumer of veterinary antimicrobial APIs in the EU. In addition, rising improvements in the animal productivity has driven growth of the animal health industry in this region. These incidences are expected to augment growth of the animal health API market in Europe.

However, the pharmaceutical industry in Europe has been concerned with potential short-term impacts of REACH regulations. This is likely to result in decreased supply of materials, or reagents, which are not preregistered by EU suppliers. In addition, dynamic changes in Europe’s macro-economic environment, such as the Brexit, has been impacting the intra-European trade and overall pharmaceutical sector. These factors might curb growth of the animal health API market in Europe.

Antiparasitics to Remain the Largest Adopted APIs in the Market

Antiparasitics will continue to be the largest adopted API in the market, followed by anti-infectives. Sales of Antiparasitics are expected to register the fastest expansion, to account for the largest revenues by 2025-end. In contrast, revenues from sales of anesthetics and NSAIDs will remain comparatively lower than antiparasitics and anti-infectives.

Get Custimized Report @ https://www.persistencemarketresearch.com/request-customization/16972

Key market players profiled in PMR’s report include Glenmark Pharmaceutical Limited., Zoetis, Inc., Eli Lilly & Co., Sanofi Winthrop Industrie (CEPiA), Indukern, S.A., Ofichem BV, P&R S.p.A (Olon S.p.A), Lonza Group AG, Huvepharma AD, Ourofino Saude Animal, Blanver Farmoquimica E Farmaceutica S.A., Zhejiang Hisun Pharmaceutical Co., Ltd, Changzhou Yabang-Qh Pharmachem Co., Ltd., Shanghai Pharmtech Co., Ltd., Ningxia Tairui Pharmaceutical Co., Ltd., Shaanxi Hanjiang Pharmaceutical Group Co., Ltd., Sequent Scientific Ltd., NGL Fine-Chem Ltd., Omkar Speciality Chemicals Ltd., Excel Industries Ltd.

More About the Report –

Unprecedented access to a world of information has given rise to the empowered, albeit distrustful, consumer. So is the case with healthcare, where the patient has been rendered more informed and conscientious thanks to the extraordinary penetration of the Internet. The discerning patient now demands more affordable, sophisticated, transparent, and personalized healthcare services, creating the need for new models for care.

The advent of health information technology (HIT) components such as electronic health records (EHR), hospital information systems (HIS), picture archiving and communication systems (PACS), and vendor-neutral archives (VNA) has had just as transformational an impact on the overall healthcare sector as the concerns regarding security and privacy. Data theft, undue access to personal health records, and cyber-attacks are very real threats that the healthcare sector faces today.

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

Animal Healthcare Market –

According to a report published by Persistence Market Research (PMR), the global animal healthcare market is expected to witness a CAGR of 4.8% from 2017 to 2025. In 2017, the market was worth US$ 30,744.2 Mn and is estimated to rise to a valuation of US$ 44,847.2 Mn by the end of 2025.

Dental Implants Market –

According to a new market report published by Persistence Market Research “Global Market Study on Dental Implants – Asia Pacific to Witness Fastest Growth by 2020,” the global Dental implants market was valued at USD 4,508.9 million in 2014 and is expected to grow at a CAGR of 9.7% from 2014 to 2020, to reach an estimated value of USD 7,879.5 million in 2020.

Globally, rising aging population has increases the demand for dental implants in the market. As a result, the market is expected to grow at a CAGR of about 9.7% from 2014 – 2020.

Bioinformatics Market –

According to a new market report published by Persistence Market Research “Global Market Study on Bioinformatics – Asia to Witness Fastest Growth by 2020,” the global bioinformatics market was valued at USD 4,110.6 million in 2014 and is expected to grow at a CAGR of 20.4% from 2014 to 2020, to reach an estimated value of USD 12,542.4 million in 2020.

Globally, rising R&D expenditures and a rising number of research activities have increased the demand for bioinformatics in the market. As a result, the market is expected to grow at a CAGR of about 20.4% from 2014 – 2020.

Hospital Beds Market – 

According to a new market report published by Persistence Market Research “Global Market Study on Hospital Beds: Asia to Witness Highest Growth by 2020”, the global hospital beds market was valued at USD 5,254.2 million in 2014 and is expected to expand at a CAGR of 4.2% from 2014 to 2020, to reach an estimated value of USD 6,731.8 million by 2020.

Cleanroom Technology Market –

According to a new market report published by Persistence Market Research titled Global Market Study on  Cleanroom Technology : Consumables to Witness Highest Growth by 2020, the global  cleanroom technology market  was valued at USD 3,156.0 million in 2014 and is expected to grow at a CAGR of 5.2 % from 2014 to 2020 to reach an estimated value of USD 4,290.1 ​​million by 2020.

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR's collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

305 Broadway, 7th Floor
New York City, NY 10007
United States
Ph.no. + 1-646-568-7751
E-mail id-  sales@persistencemarketresearch.com
Website:  https://www.persistencemarketresearch.com

 

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl